The Effect of Prenatal Hand Expression on the Rate of Exclusive Breastfeeding to Two Months
NCT ID: NCT05066438
Last Updated: 2021-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
176 participants
OBSERVATIONAL
2021-11-30
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Exploration of Antenatal Hand Expression.
NCT05307497
Early Initiation of Milk Expression in Mothers of Very Low Birth Weight Infants
NCT01892085
Integrative Early Breastfeeding Support in NICU
NCT05301309
Early Breastfeeding Cessation - is It Possible to Prevent?
NCT00145834
Early Use of Raw Milk and Breastfeeding Continuation
NCT03938675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antenatal hand expression - intention to exclusively breastfeed
Eligible participants in this group intend to exclusively breastfeed AND must have received standardized counselling on and practiced antenatal hand expression for a minimum of 10 days beginning no earlier than 36 weeks gestational age.
Antenatal hand expression
Standardized counselling and provision of information/resources on the practice of antenatal hand expression to encourage milk let down and colostrum production/collection.
No antenatal hand expression - intention to exclusively breastfeed
Eligible participants in this group intend to exclusively breastfeed but have NOT received any standardized counselling on antenatal hand expression and have not practiced antenatal hand expression OR have practiced antenatal hand expression but for less than 10 days.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antenatal hand expression
Standardized counselling and provision of information/resources on the practice of antenatal hand expression to encourage milk let down and colostrum production/collection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no contraindications to vaginal delivery
* multiple gestation only if cleared for vaginal delivery
Exclusion Criteria
* antenatal hand expression training provided by staff outside of study protocol
* practiced antenatal hand expression prior to 36 weeks gestation
* breech presentation
* history of preterm labour, preterm birth or threatened preterm labour
* history of (or current) cervical insufficiency
* any contraindication to vaginal delivery (ie. placenta or vasa previa, classical uterine scar, etc.)
* intrauterine growth restriction
* antepartum hemorrhage
* any contraindication to breastfeeding (eg. HIV)
* multiple gestation requiring Cesarean delivery
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Saskatchewan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Almereau Prollius
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Almereau Prollius, MD
Role: PRINCIPAL_INVESTIGATOR
University of Saskatchewan
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bio 2238
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.